Federated Hermes’s VivoSim Labs VIVS Stock Holding History

Federated Hermes’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-7	Closed	-$6K	–	2195
2016 Q4	$6K	Buy	7 +3	+75%	+$2.38K	﹤0.01%	1916
2016 Q3	$4K	Buy	+4	New	+$3.92K	﹤0.01%	1949

Other funds holding VIVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Federated Hermes's VIVS Position: Q1 2017 in Review

Federated Hermes sold out of VivoSim Labs (VIVS) in Q1 2017, closing a stake of 7 shares — an estimated $6K sold.

Federated Hermes first reported a position in VIVS in Q3 2016 and held it in 2 quarters. The position peaked at $6K in Q4 2016. 115 funds tracked by Wall St. Rank hold VIVS as of Q1 2017.

Federated Hermes reported no remaining VivoSim Labs position as of Q1 2017 after selling out during the quarter.
Federated Hermes sold 7 VivoSim Labs shares in Q1 2017, an estimated $6K.
Federated Hermes first reported a position in VivoSim Labs in Q3 2016 and held it in 2 quarters.
Federated Hermes's VivoSim Labs position peaked at $6K in Q4 2016.
115 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2017.

Based on Federated Hermes's 13F filing for Q1 2017, filed 12 May 2017.